When was Biotecus founded?

Biotecus was founded in 2017 and raised its 1st funding round 6 years after it was founded.

Where is Biotecus located?

Biotecus is headquartered in Vilnius, Lithuania.

Who is the current CEO of Biotecus?

Jonas Ceponis of Biotecus. They have also founded 1 company.

How many employees does Biotecus have?

As of Jul 01, 2024, the latest employee count at Biotecus is 7.

Is Biotecus a funded company?

Biotecus is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jan 09, 2023.

When was the latest funding round of Biotecus?

Biotecus' latest funding was a $***** Seed round on Jan 09, 2023, with participation from 1 investor.

Where does Biotecus rank among its competitors?

Biotecus ranks 17th amongst 24 active competitors, of which 3 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was RAMM Pharma, which secured an undisclosed amount in Sep, 2023.

Who are the top competitors of Biotecus?

Biotecus' top competitors include Purisys, MMJ and RAMM Pharma. Among them, RAMM Pharma secured the most recent funding round in September, 2023.

Biotecus - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: biotecus.com
Email ID: *****@biotecus.com
Phone Number: +370 **********

Key Metrics

Founded Year

2017

Location

Vilnius, Lithuania

Stage

Seed

Latest Funding Round

Seed, Jan 09, 2023, $*****

Investors

Tesonet

Ranked

17^th among 24 active competitors

Employee Count

7 as on Jul 01, 2024

Similar Companies

Purisys & 24 more

View Biotecus' full profile

Biotecus has raised funding over 1 round. Its latest funding round was a Seed round on Jan 09, 2023 for $*****. 1 investor participated in its latest round. Biotecus has 1 institutional investor.

Here is the list of recent funding rounds of Biotecus:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 09, 2023	4716733	Seed	8340981	9851642	4496006	5754320

Access funding benchmarks and valuations. Sign up today!

View details of Biotecus's funding rounds and investors

The founders of Biotecus is Jonas Ceponis. Jonas Ceponis is the CEO of Biotecus.

Here are the details of Biotecus' key team members:

Jonas Ceponis: Co-Founder & CEO of Biotecus.

View details of Biotecus's Founder profiles and Board Members

Biotecus' employee count trend

Biotecus has 7 employees as of Jul 24. Here is Biotecus's employee count trend over the years:

Uncover Biotecus' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biotecus include Purisys, MMJ and RAMM Pharma. Here is the list of Top 10 competitors of Biotecus, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Purisys 2019, Athens (United States), Funding Raised	Manufacturer of cannabis products	-	SK Capital	40/100
2nd	MMJ 2015, Westerly (United States), Acquired	Developer of plant-derived cannabinoid therapeutics	-	-	39/100
3rd	RAMM Pharma 1988, Toronto (Canada), Public	Provider of pharmaceutical products based on plant-derived cannabinoids	-	-	38/100
4th	Scopus BioPharma 2019, United States, Public	Manufacturer of cannabis based drugs	$9.34M	-	32/100
5th	Tetra Pharm Denmark, Series A	CDMO manufacturing and development of cannabinoid products	$12.1M	Leafy Tunnel, ENEXIS	30/100
6th	CLS Holdings USA 2014, Miami (United States), Public	Manufacturer specialising in products extracted from cannabis	-	Navy Capital	27/100
7th	Agritek Holdings 1997, Denver (United States), Public	Integrated business for cultivation of cannabis and supply of medical marijuana products	-	-	24/100
8th	FV Pharma 2012, Toronto (Canada), Public	Develops medical marijuana and cannabinoid medicines	-	FSD Pharma	23/100
9th	Averix Bio 2018, Wilson (United States), Unfunded	Developer of cannabinoid ingredients for pharmaceutical companies	-	-	23/100
10th	APIRx 2018, New York City (United States), Acquired	CDMO focused on manufacturing of cannabinoid APIs	-	-	22/100
17th	Biotecus 2017, Vilnius (Lithuania), Seed	CDMO focused on manufacturing of phytocannabinoid products	-	Tesonet	18/100